Literature DB >> 30664879

Long-term Outcomes of Fecal Microbiota Transplantation in Patients With Cirrhosis.

Jasmohan S Bajaj1, Andrew Fagan2, Edith A Gavis2, Zain Kassam3, Masoumeh Sikaroodi4, Patrick M Gillevet4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30664879      PMCID： PMC6475479          DOI： 10.1053/j.gastro.2019.01.033

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  7 in total

1.  Fecal microbiota transplantation in the management of hepatic encephalopathy.

Authors:  Dina Kao; Brandi Roach; Heekuk Park; Naomi Hotte; Karen Madsen; Vince Bain; Puneeta Tandon
Journal:  Hepatology       Date:  2015-10-01       Impact factor: 17.425

Review 2.  Healthy Donor Fecal Microbiota Transplantation in Steroid-Ineligible Severe Alcoholic Hepatitis: A Pilot Study.

Authors:  Cyriac Abby Philips; Apurva Pande; S Murali Shasthry; Kapil Dev Jamwal; Vikas Khillan; Shivendra Singh Chandel; Guresh Kumar; Manoj K Sharma; Rakhi Maiwall; Ankur Jindal; Ashok Choudhary; Md Shabbir Hussain; Shvetank Sharma; Shiv K Sarin
Journal:  Clin Gastroenterol Hepatol       Date:  2016-11-02       Impact factor: 11.382

3.  Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver.

Authors:  Hendrik Vilstrup; Piero Amodio; Jasmohan Bajaj; Juan Cordoba; Peter Ferenci; Kevin D Mullen; Karin Weissenborn; Philip Wong
Journal:  Hepatology       Date:  2014-07-08       Impact factor: 17.425

Review 4.  Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook.

Authors:  Colleen R Kelly; Stacy Kahn; Purna Kashyap; Loren Laine; David Rubin; Ashish Atreja; Thomas Moore; Gary Wu
Journal:  Gastroenterology       Date:  2015-05-15       Impact factor: 22.682

5.  Covert hepatic encephalopathy is independently associated with poor survival and increased risk of hospitalization.

Authors:  Kavish R Patidar; Leroy R Thacker; James B Wade; Richard K Sterling; Arun J Sanyal; Mohammad S Siddiqui; Scott C Matherly; R Todd Stravitz; Puneet Puri; Velimir A Luketic; Michael Fuchs; Melanie B White; Nicole A Noble; Ariel B Unser; HoChong Gilles; Douglas M Heuman; Jasmohan S Bajaj
Journal:  Am J Gastroenterol       Date:  2014-09-02       Impact factor: 10.864

6.  Changes in microbial ecology after fecal microbiota transplantation for recurrent C. difficile infection affected by underlying inflammatory bowel disease.

Authors:  Sahil Khanna; Yoshiki Vazquez-Baeza; Antonio González; Sophie Weiss; Bradley Schmidt; David A Muñiz-Pedrogo; John F Rainey; Patricia Kammer; Heidi Nelson; Michael Sadowsky; Alexander Khoruts; Stefan L Farrugia; Rob Knight; Darrell S Pardi; Purna C Kashyap
Journal:  Microbiome       Date:  2017-05-15       Impact factor: 14.650

7.  Preparing the Gut with Antibiotics Enhances Gut Microbiota Reprogramming Efficiency by Promoting Xenomicrobiota Colonization.

Authors:  Shou K Ji; Hui Yan; Tao Jiang; Chun Y Guo; Jing J Liu; Shuang Z Dong; Kai L Yang; Ya J Wang; Zhi J Cao; Sheng L Li
Journal:  Front Microbiol       Date:  2017-06-28       Impact factor: 5.640
  7 in total
  31 in total

Review 1.  Recipient factors in faecal microbiota transplantation: one stool does not fit all.

Authors:  Camille Danne; Nathalie Rolhion; Harry Sokol
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-04-27       Impact factor: 46.802

Review 2.  Contribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders.

Authors:  Daniel M Chopyk; Arash Grakoui
Journal:  Gastroenterology       Date:  2020-06-20       Impact factor: 22.682

3.  Fecal Microbial Transplant Capsules Are Safe in Hepatic Encephalopathy: A Phase 1, Randomized, Placebo-Controlled Trial.

Authors:  Jasmohan S Bajaj; Nita H Salzman; Chathur Acharya; Richard K Sterling; Melanie B White; Edith A Gavis; Andrew Fagan; Michael Hayward; Mary L Holtz; Scott Matherly; Hannah Lee; Majdi Osman; Mohammad S Siddiqui; Michael Fuchs; Puneet Puri; Masoumeh Sikaroodi; Patrick M Gillevet
Journal:  Hepatology       Date:  2019-06-18       Impact factor: 17.425

Review 4.  Utilizing the gut microbiome in decompensated cirrhosis and acute-on-chronic liver failure.

Authors:  Jonel Trebicka; Peer Bork; Aleksander Krag; Manimozhiyan Arumugam
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-11-30       Impact factor: 46.802

5.  Albumin therapy for hepatic encephalopathy: current evidence and controversies.

Authors:  Yu Jun Wong; Jing Hong Loo
Journal:  Metab Brain Dis       Date:  2022-05-26       Impact factor: 3.584

6.  Long-term Outcomes of Stool Transplant in Alcohol-associated Hepatitis-Analysis of Clinical Outcomes, Relapse, Gut Microbiota and Comparisons with Standard Care.

Authors:  Cyriac A Philips; Rizwan Ahamed; Sasidharan Rajesh; Jinsha K P Abduljaleel; Philip Augustine
Journal:  J Clin Exp Hepatol       Date:  2022-01-08

Review 7.  Promises of microbiome-based therapies.

Authors:  Jasmohan S Bajaj; Siew C Ng; Bernd Schnabl
Journal:  J Hepatol       Date:  2022-06       Impact factor: 30.083

Review 8.  Gut Barrier and Microbiota in Cirrhosis.

Authors:  Cyriac A Philips; Philip Augustine
Journal:  J Clin Exp Hepatol       Date:  2021-09-03

Review 9.  Acute Radiation Syndrome and the Microbiome: Impact and Review.

Authors:  Brynn A Hollingsworth; David R Cassatt; Andrea L DiCarlo; Carmen I Rios; Merriline M Satyamitra; Thomas A Winters; Lanyn P Taliaferro
Journal:  Front Pharmacol       Date:  2021-05-18       Impact factor: 5.810

10.  Neuroinflammation in Murine Cirrhosis Is Dependent on the Gut Microbiome and Is Attenuated by Fecal Transplant.

Authors:  Runping Liu; Jason D Kang; R Balfour Sartor; Masoumeh Sikaroodi; Andrew Fagan; Edith A Gavis; Huiping Zhou; Phillip B Hylemon; Jeremy W Herzog; Xiaojiaoyang Li; Robert H Lippman; Javier Gonzalez-Maeso; James B Wade; Siddhartha Ghosh; Emily Gurley; Patrick M Gillevet; Jasmohan S Bajaj
Journal:  Hepatology       Date:  2019-08-19       Impact factor: 17.298
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.